TRDA (Entrada Therapeutics, Inc.) — Stock Analysis, Catalysts & AI Research

Entrada Therapeutics, Inc.

$7.11

Health CareBiotechnology

The Read: 2% on positive clinical updates and stable cash runway but then plunged about 9.

Price

Overlays

Panel

TRDA

Hover to view data

No Data

The Stats

Market Cap

N/A

Total outstanding shares value

Earnings Per Share (EPS)

N/A

Latest reported

Net Profit Margin

N/A

Net Income / Revenue

Revenue Growth (YoY)

N/A

Prior year same period

Debt / Equity

N/A

Leverage risk indicator

Dividend Yield

0.00%

Annualized Return

Free Cash Flow

N/A

No data

Entrada Therapeutics, Inc.

$7.11

Health CareBiotechnology

The Read: 2% on positive clinical updates and stable cash runway but then plunged about 9.

Price

Overlays

Panel

TRDA

Hover to view data

No Data

The Stats

Market Cap

N/A

Total outstanding shares value

Earnings Per Share (EPS)

N/A

Latest reported

Net Profit Margin

N/A

Net Income / Revenue

Revenue Growth (YoY)

N/A

Prior year same period

Debt / Equity

N/A

Leverage risk indicator

Dividend Yield

0.00%

Annualized Return

Free Cash Flow

N/A

No data

Create your free account to unlock active Expected Moves for TRDA

Expected Moves

Entrada Therapeutics, Inc.

The Stats

Market Cap

Earnings Per Share (EPS)

Net Profit Margin

Revenue Growth (YoY)

Debt / Equity

Dividend Yield

Free Cash Flow

Create your free account to unlock active Expected Moves for TRDA

Expected Moves

Entrada Therapeutics, Inc.

The Stats

Market Cap

Earnings Per Share (EPS)

Net Profit Margin

Revenue Growth (YoY)

Debt / Equity

Dividend Yield

Free Cash Flow